NASDAQ : ADAP

Adaptimmune Therapeutics plc

$0.0485 USD

$0.0 (-3.0%)

Volume
1.68M
Average Volume
110.64M
Market Capitalization
$75.16M
P/E Ratio
-0.16
Dividend Yield
0.00%
Price Target
$3.00
Year High
$0.86
Year Low
$0.02
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.52
Source Headline
Merck Announces New Agreement with ADAP Crisis Task Force to Improve Access and Care for People Living with HIV

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces Agreement to Improve Treatment Access for People Living with HIV. Agreement will help state ADAP programs provide access to IDVYNSO.

businesswire.com - 2026-06-29 06:45:00

Get ADAP Insider Trade Alerts

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

ADAP Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$0.00

0 analysts

All Time

$2.83

5 analysts

ADAP Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade